Skip to main content

ULTRA Duramune DAP + C4L

This page contains information on ULTRA Duramune DAP + C4L for veterinary use.
The information provided typically includes the following:
  • ULTRA Duramune DAP + C4L Indications
  • Warnings and cautions for ULTRA Duramune DAP + C4L
  • Direction and dosage information for ULTRA Duramune DAP + C4L

ULTRA Duramune DAP + C4L

This treatment applies to the following species:
Company: Elanco US

Canine Distemper-Adenovirus Type 2-Coronavirus-Parvovirus Vaccine

Modified Live and Killed Virus

Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract

For use in animals only

This product has been shown to be effective for the vaccination of healthy dogs 6 weeks of age or older against canine distemper, infectious canine hepatitis, canine adenovirus type 2, canine coronavirus, canine parvovirus (CPV), Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae and Leptospira pomona. The duration of immunity for this product has not been determined. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

This product contains a CPV 2b strain which has been demonstrated effective against disease caused by CPV 2c in puppies with CPV maternal antibody.

Directions For Use

General directions: Aseptically rehydrate ULTRA Duramune DAP with low volume diluent supplied. Administer one 0.5 mL dose subcutaneously.

Primary vaccination: The presence of maternal antibody is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals.
All dogs should initially receive one dose of this product and a second dose 2 to 3 weeks later.

Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended.

ULTRA Duramune DAP + C4L Caution

Store in the dark at 2° to 8°C (35° to 46°F). AVOID FREEZING. SHAKE WELL. Do not mix with other products, except as specified on the label. This product has not been tested in pregnant animals. In case of anaphylactoid reaction, administer epinephrine. Inactivate all unused contents before disposal. In case of human exposure, contact a physician.

Gentamicin and thimerosal added as preservatives.

ULTRA Duramune DAP + C4L Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

Ultra, Duramune, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

© 2017 Elanco US Inc. all rights reserved.

Elanco US Inc., Fort Dodge, IA 50501

Phone: 888-545-5973

VLN/PCN 196/45J9.20

25 Doses: 25 Vials of Vaccine plus 25 x 0.5 mL Vials of Diluent

YL102088X

CPN: 1943021.2

ELANCO US INC.
Distributed by ELANCO US, INC.
2500 INNOVATION WAY, GREENFIELD, IN, 46140
Customer Service:   317-276-1262
Technical Service:   800-428-4441
Website:   www.elanco.us
Email:   elanco@elanco.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Copyright © 2024 Animalytix LLC. Updated: 2024-02-27